Full name
SUPER-PHARM POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.11.Z - Non-specialized retail trade with a predominance of food, beverages, or tobacco products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.51.Z - Retail sale of textile products
47.71.Z - Retail sale of clothing
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
96.02.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -24,8 | -24,8 | 14 | 156,6 |
EBITDA | -9,9 | -9,9 | 53,4 | 639 |
Short time liabilities | 221,1 | 221,1 | 274,6 | 24,2 |
Equity capital | 106,3 | 106,3 | 146,5 | 37,9 |
Operating profit (EBIT) | -20,4 | -20,4 | 30,2 | 248,1 |
Assets | 340,9 | 340,9 | 444 | 30,2 |
Net profit (loss) | -25,7 | -25,7 | 5,5 | 121,5 |
Cash | 15,1 | 15,1 | 8,9 | -40,7 |
Net income from sale | 723,3 | 723,3 | 1943,3 | 168,7 |
Liabilities and provisions for liabilities | 234,6 | 234,6 | 297,5 | 26,8 |
Working assets | 218,6 | 218,6 | 302,1 | 38,2 |
Depreciation | 10,5 | 10,5 | 23,2 | 121,4 |
% | % | % | p.p. | |
Profitability of capital | -24,2 | -24,2 | 3,8 | 28 |
Equity capital to total assets | 31,2 | 31,2 | 33 | 1,8 |
Gross profit margin | -3,4 | -3,4 | 0,7 | 4,1 |
EBITDA Margin | -1,4 | -1,4 | 2,7 | 4,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 112 | 112 | 52 | -60 |
Current financial liquidity indicator | 0.9847389459609985 | 0.9847389459609985 | 1.0940595865249634 | 0,1 |
Net dept to EBITDA | -14.060959815979004 | -14.060959815979004 | 2.18052339553833 | 16,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane